Literature DB >> 8182403

Diabetic foot ulcers in a multidisciplinary setting. An economic analysis of primary healing and healing with amputation.

J Apelqvist1, G Ragnarson-Tennvall, U Persson, J Larsson.   

Abstract

OBJECTIVES: To perform an economic analysis of primary healing and healing with amputation in diabetic patients with foot ulcers.
DESIGN: A retrospective economic analysis based on a prospective study of consecutively presenting diabetic patients admitted to the Department of Internal Medicine because of foot ulcer.
SETTING: A multidisciplinary foot-care team.
SUBJECTS: A total of 314 consecutively presenting diabetic patients with foot ulcers. Forty patients died before healing occurred. In those patients who healed primarily (n = 197) or after amputation (n = 77), a retrospective economic analysis was performed.
INTERVENTIONS: All patients were treated by a multidisciplinary foot care team consisting of diabetologist, orthopaedic surgeon, diabetes nurse, podiatrist and orthotist both as in- and out-patients. The patients were followed by the team from admittance until final outcome, i.e. primary healing or healing with amputation or death. MAIN OUTCOME MEASURES: Data from both the prospectively collected patient material and from patient records were used to estimate the cost for hospital care, antibiotics, surgery, out-patient care, staff attendance, drugs and material for ulcer dressings, and orthopaedic appliances.
RESULTS: The total costs were SEK 51,000 (3000-808,000) for patients with primary healing and SEK 344,000 (27,000-992,000) for healing with amputation. Costs for in-patient care were 37% of total average costs for primary healing and 82% for patients with amputation. The costs for topical treatment of the ulcers in out-patient care were 45% of the total average cost for primary healed and 13% for patients who healed with amputation. The costs for products used for ulcer dressings were 21% of total costs for topical treatment, i.e. 9% and 3% of total average costs for primary healing and healing with amputation, respectively. Costs for visits to the foot care team, antibiotics and orthopaedic appliances were low in relation to total costs.
CONCLUSION: Treatment of diabetic patients with foot ulcers in a multidisciplinary system was associated with relatively low costs. Healing with amputation was associated with high costs mainly due to multiple and extended hospitalization. These findings indicate the potential cost savings of preventive and multidisciplinary foot care.

Entities:  

Mesh:

Year:  1994        PMID: 8182403     DOI: 10.1111/j.1365-2796.1994.tb01104.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  28 in total

Review 1.  Cost-effective management of diabetic foot ulcers. A review.

Authors:  G Ragnarson-Tennvall; J Apelqvist
Journal:  Pharmacoeconomics       Date:  1997-07       Impact factor: 4.981

2.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

Review 3.  Model-based evaluation of diabetic foot prevention strategies in Austria.

Authors:  Marion S Rauner; Kurt Heidenberger; Eva-Maria Pesendorfer
Journal:  Health Care Manag Sci       Date:  2005-11

Review 4.  Evaluation of the quality and cost-effectiveness of Versajet hydrosurgery.

Authors:  David C G Sainsbury
Journal:  Int Wound J       Date:  2009-02       Impact factor: 3.315

Review 5.  Extracorporeal shockwave therapy for the treatment of chronic wound of lower extremity: current perspective and systematic review.

Authors:  Mohammed Ta Omar; Rehab Fm Gwada; Afaf Am Shaheen; Raoul Saggini
Journal:  Int Wound J       Date:  2017-02-15       Impact factor: 3.315

6.  A review of the Eurodiale studies: what lessons for diabetic foot care?

Authors:  Simeen Akhtar; Nicolaas Schaper; Jan Apelqvist; Edward Jude
Journal:  Curr Diab Rep       Date:  2011-08       Impact factor: 4.810

Review 7.  Costs of insulin-dependent diabetes mellitus.

Authors:  T T Simell; H Sintonen; J Hahl; O G Simell
Journal:  Pharmacoeconomics       Date:  1996-01       Impact factor: 4.981

8.  The cost effectiveness of Apligraf treatment of diabetic foot ulcers.

Authors:  W Ken Redekop; Joseph McDonnell; Paul Verboom; Kornelia Lovas; Zoltan Kalo
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

9.  Trends and determinants of costs associated with the inpatient care of diabetic foot ulcers.

Authors:  Caitlin W Hicks; Shalini Selvarajah; Nestoras Mathioudakis; Bruce A Perler; Julie A Freischlag; James H Black; Christopher J Abularrage
Journal:  J Vasc Surg       Date:  2014-06-14       Impact factor: 4.268

Review 10.  Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.

Authors:  Astrid Langer; Wolf Rogowski
Journal:  BMC Health Serv Res       Date:  2009-07-10       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.